98 related articles for article (PubMed ID: 29420763)
1. Analysis of the in vitro activity of human neutrophils against Aspergillus fumigatus in presence of antifungal and immunosuppressive agents.
Decker C; Wurster S; Lazariotou M; Hellmann AM; Einsele H; Ullmann AJ; Löffler J
Med Mycol; 2018 Jun; 56(4):514-519. PubMed ID: 29420763
[TBL] [Abstract][Full Text] [Related]
2. Amphotericin B formulations exert additive antifungal activity in combination with pulmonary alveolar macrophages and polymorphonuclear leukocytes against Aspergillus fumigatus.
Roilides E; Lyman CA; Filioti J; Akpogheneta O; Sein T; Lamaignere CG; Petraitiene R; Walsh TJ
Antimicrob Agents Chemother; 2002 Jun; 46(6):1974-6. PubMed ID: 12019118
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil extracellular trap formation is elicited in response to cold physical plasma.
Bekeschus S; Winterbourn CC; Kolata J; Masur K; Hasse S; Bröker BM; Parker HA
J Leukoc Biol; 2016 Oct; 100(4):791-799. PubMed ID: 26992432
[TBL] [Abstract][Full Text] [Related]
4. Antifungal Drugs Influence Neutrophil Effector Functions.
Ries F; Alflen A; Aranda Lopez P; Beckert H; Theobald M; Schild H; Teschner D; Radsak MP
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910895
[TBL] [Abstract][Full Text] [Related]
5. Amphotericin B formulations variably enhance antifungal activity of human neutrophils and monocytes against Fusarium solani: comparison with Aspergillus fumigatus.
Dotis J; Simitsopoulou M; Dalakiouridou M; Konstantinou T; Panteliadis C; Walsh TJ; Roilides E
J Antimicrob Chemother; 2008 Apr; 61(4):810-7. PubMed ID: 18272514
[TBL] [Abstract][Full Text] [Related]
6. Effects of lipid formulations of amphotericin B on activity of human monocytes against Aspergillus fumigatus.
Dotis J; Simitsopoulou M; Dalakiouridou M; Konstantinou T; Taparkou A; Kanakoudi-Tsakalidou F; Walsh TJ; Roilides E
Antimicrob Agents Chemother; 2006 Mar; 50(3):868-73. PubMed ID: 16495244
[TBL] [Abstract][Full Text] [Related]
7. In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus isolates from transplant and nontransplant patients.
Steinbach WJ; Singh N; Miller JL; Benjamin DK; Schell WA; Heitman J; Perfect JR
Antimicrob Agents Chemother; 2004 Dec; 48(12):4922-5. PubMed ID: 15561883
[TBL] [Abstract][Full Text] [Related]
8. IL-10 exerts suppressive and enhancing effects on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus.
Roilides E; Dimitriadou A; Kadiltsoglou I; Sein T; Karpouzas J; Pizzo PA; Walsh TJ
J Immunol; 1997 Jan; 158(1):322-9. PubMed ID: 8977206
[TBL] [Abstract][Full Text] [Related]
9. Does hydrocortisone modify the in vitro susceptibility of Aspergillus fumigatus to itraconazole and amphotericin B?
Ramondenc I; Pinel C; Ambroise-Thomas P; Grillot R
Med Mycol; 1998 Apr; 36(2):69-73. PubMed ID: 9776816
[TBL] [Abstract][Full Text] [Related]
10. Phase-dependent antifungal activity against Aspergillus fumigatus developing multicellular filamentous biofilms.
Mowat E; Lang S; Williams C; McCulloch E; Jones B; Ramage G
J Antimicrob Chemother; 2008 Dec; 62(6):1281-4. PubMed ID: 18819968
[TBL] [Abstract][Full Text] [Related]
11. Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B.
Warn PA; Morrissey G; Morrissey J; Denning DW
J Antimicrob Chemother; 2003 Apr; 51(4):913-9. PubMed ID: 12654746
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the in-vitro activity of voriconazole (UK-109,496), itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatus.
Cuenca-Estrella M; Rodríguez-Tudela JL; Mellado E; Martínez-Suárez JV; Monzón A
J Antimicrob Chemother; 1998 Oct; 42(4):531-3. PubMed ID: 9818755
[TBL] [Abstract][Full Text] [Related]
13. Synergistic interaction of the triple combination of amphotericin B, ciprofloxacin, and polymorphonuclear neutrophils against Aspergillus fumigatus.
Stergiopoulou T; Meletiadis J; Sein T; Papaioannidou P; Walsh TJ; Roilides E
Antimicrob Agents Chemother; 2011 Dec; 55(12):5923-9. PubMed ID: 21911564
[TBL] [Abstract][Full Text] [Related]
14. The in vitro effects of interferon-gamma, alone or in combination with amphotericin B, tested against the pathogenic fungi Candida albicans and Aspergillus fumigatus.
El-Khoury M; Ligot R; Mahoney S; Stack CM; Perrone GG; Morton CO
BMC Res Notes; 2017 Aug; 10(1):364. PubMed ID: 28764751
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of fungicidal activities of voriconazole and amphotericin B against hyphae of Aspergillus fumigatus.
Krishnan S; Manavathu EK; Chandrasekar PH
J Antimicrob Chemother; 2005 Jun; 55(6):914-20. PubMed ID: 15824093
[TBL] [Abstract][Full Text] [Related]
16. Human Neutrophils Produce Antifungal Extracellular Vesicles against Aspergillus fumigatus.
Shopova IA; Belyaev I; Dasari P; Jahreis S; Stroe MC; Cseresnyés Z; Zimmermann AK; Medyukhina A; Svensson CM; Krüger T; Szeifert V; Nietzsche S; Conrad T; Blango MG; Kniemeyer O; von Lilienfeld-Toal M; Zipfel PF; Ligeti E; Figge MT; Brakhage AA
mBio; 2020 Apr; 11(2):. PubMed ID: 32291301
[TBL] [Abstract][Full Text] [Related]
17. In-vitro activities of amphotericin B, itraconazole and voriconazole against 150 clinical and environmental Aspergillus fumigatus isolates.
Verweij PE; Mensink M; Rijs AJ; Donnelly JP; Meis JF; Denning DW
J Antimicrob Chemother; 1998 Sep; 42(3):389-92. PubMed ID: 9786480
[TBL] [Abstract][Full Text] [Related]
18. Post-antifungal effect of amphotericin B and voriconazole against germinated Aspergillus fumigatus conidia.
Chryssanthou E; Loebig A; Sjölin J
J Antimicrob Chemother; 2008 Jun; 61(6):1309-11. PubMed ID: 18367461
[TBL] [Abstract][Full Text] [Related]
19. Induction of Mitochondrial Reactive Oxygen Species Production by Itraconazole, Terbinafine, and Amphotericin B as a Mode of Action against Aspergillus fumigatus.
Shekhova E; Kniemeyer O; Brakhage AA
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848005
[TBL] [Abstract][Full Text] [Related]
20. Collaboration of human phagocytes with LY 303366 for antifungal activity against Aspergillus fumigatus.
Brummer E; Chauhan SD; Stevens DA
J Antimicrob Chemother; 1999 Apr; 43(4):491-6. PubMed ID: 10350377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
